Literature DB >> 14722306

Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.

Frank Scholle1, Kui Li, Francis Bodola, Masanori Ikeda, Bruce A Luxon, Stanley M Lemon.   

Abstract

Considerable controversy surrounds the impact of hepatitis C virus (HCV) protein expression on viability of host cells and regulation of the cell cycle. Both promotion of cellular proliferation and apoptosis have been observed in different experimental systems. To determine whether expression of the entire complement of HCV proteins in the context of ongoing viral RNA replication significantly alters the host cell transcriptome and cell cycle regulatory processes, we carried out high-density oligonucleotide microarray studies and analyzed cell cycle distributions and S-phase entry in Huh7 cell clones harboring selectable, full-length, replicating HCV RNAs that express the entire genotype 1b, HCV-N polyprotein, and clonally related cells in which all viral RNA was eliminated by prior treatment with alpha interferon. Oligonucleotide microarray analyses revealed only subtle, coordinated differences in the mRNA profiles of cells containing replicating viral RNA and their interferon-cured progeny, with variation between different cell clones having a greater influence on the cellular transcriptome than the presence or absence of replicating HCV RNA. Flow cytometric analysis demonstrated no significant differences in cell cycle distribution among populations of asynchronously growing cells of both types. Cell lines containing replicating viral RNA and their interferon-cured progeny were able to reenter the cell cycle similarly after transient G(1) arrest. In contrast, although viral protein expression and genome replication did not alter cell cycle control in these cells, HCV genome replication was highly dependent on cellular proliferation, with viral RNA synthesis strongly decreased in poorly proliferating, confluent, or serum-starved cells and substantially enhanced in the S phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722306      PMCID: PMC321413          DOI: 10.1128/jvi.78.3.1513-1524.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation.

Authors:  E Y Jung; M N Lee; H Y Yang; D Yu; K L Jang
Journal:  Virus Res       Date:  2001-11-05       Impact factor: 3.303

3.  Suppression of serum starvation-induced apoptosis by hepatitis C virus core protein.

Authors:  M Takamatsu; T Fujita; H Hotta
Journal:  Kobe J Med Sci       Date:  2001-04

4.  Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation.

Authors:  R Bartenschlager; V Lohmann; T Wilkinson; J O Koch
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.

Authors:  Thomas Pietschmann; Volker Lohmann; Artur Kaul; Nicole Krieger; Gabriele Rinck; Gabriel Rutter; Dennis Strand; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 6.  Novel cell culture systems for the hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  Antiviral Res       Date:  2001-10       Impact factor: 5.970

7.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

8.  Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth.

Authors:  A K Ghosh; R Steele; K Meyer; R Ray; R B Ray
Journal:  J Gen Virol       Date:  1999-05       Impact factor: 3.891

9.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.

Authors:  M J Gale; M J Korth; N M Tang; S L Tan; D A Hopkins; T E Dever; S J Polyak; D R Gretch; M G Katze
Journal:  Virology       Date:  1997-04-14       Impact factor: 3.616

10.  In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor.

Authors:  J O Koch; V Lohmann; U Herian; R Bartenschlager
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

View more
  45 in total

1.  The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein.

Authors:  Kanchan Bhardwaj; Pinghua Liu; Julian L Leibowitz; C Cheng Kao
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

3.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Identification of novel human kinases that suppress hepatitis C virus infection.

Authors:  A Lee; S Liu; T Wang
Journal:  J Viral Hepat       Date:  2013-11-10       Impact factor: 3.728

5.  Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis.

Authors:  Takashi Kato; Takahiro Okai; Takuya Shiroma; Junko Fukuda; Ryuichi Yokohari; Masao Tadokoro
Journal:  Clin Rheumatol       Date:  2004-11-30       Impact factor: 2.980

Review 6.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

7.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 8.  Roles of regulated intramembrane proteolysis in virus infection and antiviral immunity.

Authors:  Jin Ye
Journal:  Biochim Biophys Acta       Date:  2013-12

9.  Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.

Authors:  Yuki Nishimura-Sakurai; Naoya Sakamoto; Kaoru Mogushi; Satoshi Nagaie; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka-Fujita; Yuko Onuki-Karakama; Goki Suda; Kako Mishima; Machi Yamamoto; Mayumi Ueyama; Yusuke Funaoka; Takako Watanabe; Seishin Azuma; Yuko Sekine-Osajima; Sei Kakinuma; Kiichiro Tsuchiya; Nobuyuki Enomoto; Hiroshi Tanaka; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-12-12       Impact factor: 7.527

10.  Intracellular restriction of a productive noncytopathic coronavirus infection.

Authors:  Olga Slobodskaya; Alexander Laarman; Willy J M Spaan
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.